Teva Pharmaceutical Industries News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.03.16	Teva Launches Generic Campral In U.S. - Quick Facts (RTTNews)
10.03.16	Teva Gets EU Regulatory Approval For Acquisition Of Allergan's Global Business (RTTNews)
24.02.16	Teva Plans To Introduce New Brand To Employees Over Next 12 Months - Quick Facts (RTTNews)
11.02.16	Teva Profit Down, Misses View, Revenues Beat; Sees Q1 Revenues Below Estimates (RTTNews)
11.02.16	EARNINGS SUMMARY: Details of Teva Pharmaceutical Industries Limited Q4 Earnings Report (RTTNews)
02.02.16	Teva To Collaborates With AbCellera For Discovery Of Monoclonal Antibodies (RTTNews)
07.01.16	Teva, Checkpoint Therapeutics Report License Agreement For Oral PARP Inhibitor (RTTNews)
05.01.16	Teva Launches Generic Ortho Tri-Cyclen - Quick Facts (RTTNews)
04.01.16	Teva, Active Biotech To Stop Higher Dose Studies Of Laquinimod In MS Trial (RTTNews)
28.12.15	Takeda Announces Details Of New Business Venture With Teva In Japan (RTTNews)
14.12.15	Antares Pharma Gets FDA Approval For Sumatriptan Injection USP - Quick Facts (RTTNews)
14.12.15	CTI BioPharma Gets $10 Mln Milestone Payment From Teva For TRISENOX (RTTNews)
10.12.15	Teva: FDA Panel Recommends Approval Of Reslizumab In Patients 18 Years, Older (RTTNews)
08.12.15	Teva, Eagle Pharma Report FDA Approval Of BENDEKA Injection (RTTNews)
03.12.15	Teva Pharma Prices Concurrent Offerings Totaling $6.75 Bln (RTTNews)
30.11.15	Teva Pharma Starts Concurrent Offerings Of About $6.75 Bln To Fund Acquisitions (RTTNews)
30.11.15	Teva, Takeda Sign Deal To Establish Business Venture In Japan - Quick Facts (RTTNews)
25.11.15	Teva To Receive Development And Commercial Rights To Novel CGRP Antagonists (RTTNews)
23.11.15	Pfizer And Allergan To Merge In $160 Bln Deal (RTTNews)
19.11.15	Teva Reports Results On Fluticasone Propionate/Salmeterol,Fluticasone Propionate (RTTNews)
09.11.15	Teva Says FDA Grants SD-809 Breakthrough Therapy Designation - Quick Facts (RTTNews)
02.11.15	ALXA Gets It Back, REGN's Eylea Keeps Adding New Indications, Smooth Flows PTLA (RTTNews)
29.10.15	Pfizer Confirms Preliminary Merger Talks With Allergan - Quick Facts (RTTNews)
29.10.15	Allergan Confirms Talks On Potential Combination With Pfizer - Quick Facts (RTTNews)
29.10.15	Teva Boosts FY EPS View (RTTNews)
29.10.15	Teva Pharmaceutical Industries Limited Reports 2% Advance In Q3 Bottom Line (RTTNews)
12.10.15	Teva Launches Generic Avodart Capsules - Quick Facts (RTTNews)
08.10.15	Teva Announces Approval Of COPAXONE 40 Mg/mL In Russia - Quick Facts (RTTNews)
01.10.15	Teva Pharma To Acquire Mexico's Rimsa For $2.3 Bln (RTTNews)
01.10.15	Teva To Acquire Rimsa In $2.3 Bln Deal - Quick Facts (RTTNews)
30.09.15	New Data From Teva's TEV-48125 Phase 2B Migraine Program Published (RTTNews)
28.09.15	Teva Announces Approval Of COPAXONE In Japan - Quick Facts (RTTNews)
25.09.15	Teva To Acquire Privately-held Gecko Health Innovations - Quick Facts (RTTNews)
01.09.15	Teva Announces U.S. Availability Of ZECUITY For Migraine (RTTNews)
17.08.15	Mesoblast FY Loss Widens; Update On Phase 3 Chronic Heart Failure Program (RTTNews)
12.08.15	Teva: FDA Accepts NDA For SD-809 For Treatment In Huntington Disease (RTTNews)
03.08.15	Teva To Purchase 51% Equity Share Of The Genomic-analysis Company Immuneering (RTTNews)
31.07.15	Teva Secures $33.75 Bln Financing Commitment (RTTNews)
30.07.15	EARNINGS SUMMARY: Details of Teva Pharmaceutical Industries Limited Q2 Earnings Report (RTTNews)
30.07.15	Teva Q2 Attributable Net Income Falls, Ups Full Year EPS View (RTTNews)
28.07.15	Teva Files MAA With European Medicines Agency For Reslizumab - Quick Facts (RTTNews)
27.07.15	Mylan Welcomes Teva's Decision - Quick Facts (RTTNews)
27.07.15	Teva To Buy Allergan Generics For $40.5 Bln Cash, Stock; Shares Up (RTTNews)
27.07.15	Teva Reports Q2 EPS Of $1.43, Lifts FY Earnings Outlook; Stock Up In Pre-market (RTTNews)
27.07.15	Teva To Buy Allergan Generics For $40.5 Bln; Withdraws Offer For Mylan (RTTNews)
27.07.15	Allergan To Acquire Naurex For $560 Mln In Cash (RTTNews)
26.07.15	WSJ: Teva In Talks To Buy Allergan's Generic Drug Unit For About $45 Bln (RTTNews)
23.07.15	Mylan Foundation Exercises Call Option To Buy 488.39 Mln Mylan Preferred Shares (RTTNews)
13.07.15	ANI Pharmaceuticals Acquires 22 Generic Drug Products From Teva For $25 Mln (RTTNews)
07.07.15	AstraZeneca, Teva's Cephalon Settle Allegations Of Underpaying Medicaid Rebates (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold